Rosuvastatin Glenmark 40 mg Norge - norsk - Statens legemiddelverk

rosuvastatin glenmark 40 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg

Rosuvastatin Glenmark 5 mg Norge - norsk - Statens legemiddelverk

rosuvastatin glenmark 5 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg

Rosuvastatin Glenmark 10 mg Norge - norsk - Statens legemiddelverk

rosuvastatin glenmark 10 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg

Rosuvastatin Glenmark 20 mg Norge - norsk - Statens legemiddelverk

rosuvastatin glenmark 20 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg

Orserdu Den europeiske union - norsk - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Rosuvastatin Sandoz 10 mg Norge - norsk - Statens legemiddelverk

rosuvastatin sandoz 10 mg

sandoz - københavn - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg

Rosuvastatin Sandoz 5 mg Norge - norsk - Statens legemiddelverk

rosuvastatin sandoz 5 mg

sandoz - københavn - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg

Rosuvastatin Sandoz 20 mg Norge - norsk - Statens legemiddelverk

rosuvastatin sandoz 20 mg

sandoz - københavn - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg

Rosuvastatin Sandoz 40 mg Norge - norsk - Statens legemiddelverk

rosuvastatin sandoz 40 mg

sandoz - københavn - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg

Rosuvastatin Xiromed 20 mg Norge - norsk - Statens legemiddelverk

rosuvastatin xiromed 20 mg

medical valley invest ab - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg